glp-1 and macular degeneration The potential risk of age-related with drugs in people with diabetes https://t.co/BoGo9iTutV GLP-1s for Weight Loss May

Hengrui Pharma and Kailera Therapeutics presented new ADA 2026 data for ribupatide (HRS9531 / KAI-9531), a GLP-1/GIP dual agonist being developed as both a once-weekly injection and a once-daily oral therapy for obesity and overweight

Discover the mechanisms and uses of GLP-1 agonist drugs, including their role in the treatment of type 2 diabetes and weight loss.

Some theories suggest semaglutide may affect the absorption of the birth control pill, but more research is necessary

Long-acting glucagon-like peptide (GLP)-1 analogs are currently available in treating diabetes with widely established safety and extensively evaluated efficacy

Collagen for Hair, Skin & Appearance: Includes 5g collagen peptides along with biotin, zinc, and vitamin C to support hair and skin health